Vittorio Ruggero Zilioli

Author

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda ORCID

Also Known As

Manuela Zanni, V ZILIOLI, V Zilioli, V. R Zilioli, V. R. Zilioli, V. Zilioli, V.R. Zilioli, Vittorio Ruggero Zilioli, Vittorio R Zilioli, Vittorio R. Zilioli

131

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda Istituti di Ricovero e Cura a Carattere Scientifico Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Azienda Ospedaliera Citta' della Salute e della Scienza di Torino Sapienza University of Rome

About

Vittorio Ruggero Zilioli is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	438
2	Health Sciences	5	5	250
3	Geriatrics	2	2	165
4	Emergency Medicine	1	1	38
5	Epidemiology	1	1	38

Vittorio Ruggero Zilioli

Publications

960

Citations

H-Index

Page 1

	Year	Citations
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi Francesco Merli, Stefano Luminari, Alessandra Tucci, Journal of Clinical Oncology AgingPrognosisPathologyGeriatric MedicineLongevity	2021	149
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study Carlo Visco, Alice Di Rocco, Andrea Evangelista, Leukemia Lymphoid NeoplasiaMantle Cell LymphomaMedicinePathologyMantle-first Study	2020	97
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study Armando Santoro, Rita Mazza, Alessandro Pulsoni, Journal of Clinical Oncology	2016	95
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study Stefano Luminari, Martina Manni, Sara Galimberti, Journal of Clinical Oncology	2021	83
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution Franca Radaelli, Francesco Onida, Francesca Gaia Rossi, Hematology	2008	42
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma Armando Santoro, Rita Mazza, Alessandro Pulsoni, Blood Advances	2020	40
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H Agostino Cortelezzi, M Viganò, Vittorio Ruggero Zilioli, Journal of Clinical Virology Hematological MalignancyViral HepatitisMedicineHematologyImmunology	2005	39
Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia Franca Radaelli, Rossella Calori, Vittorio Ruggero Zilioli, Hematological Oncology Essential ThrombocythemiaConsecutive Et PatientsThrombosisVenous ThrombosisStroke	2007	38
<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study Martin Dreyling, Lucie Obéric, Eva Giné, British Journal of Haematology Hematological MalignancyLymphoid NeoplasiaOncologyMantle Cell LymphomaMalignant Blood Disorder	2022	37
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience Vittorio Ruggero Zilioli, Domenico Albano, Annalisa Arcari, Journal of Cachexia Sarcopenia and Muscle	2021	29

Page 1